English
简体中文
Total: £ 56.28
Published Date: 2024-04-07 | Pages: 128 | Tables: 234 | Pharma & Healthcare
The anti-rinderpest virus antibody produced after immunization with rinderpest virus vaccine can resist the attack of Peste des petits ruminants virus, and has a good immune protection effect. Injection of rinderpest virus vaccine is an important measure to control the outbreak and prevalence of the disease in beef cattle farms.
The global market for Rinderpest Virus Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rinderpest Virus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Rinderpest Virus Vaccine by region & country, by Type, and by Application.
The Rinderpest Virus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rinderpest Virus Vaccine.
Market Segmentation
By Company
Zoetis
Merck Animal Health
Hipra
Boehringer-Ingelheim
Ceva
Creative Biolabs
China Animal Husbandry Industry
Jinyu Bio-technology
TECON
Shenzhen Huaweite Biotechnology
Beijing Centrebio Biology
Guangdong Winsun Bio Pharmaceutical
SPAH
Wuhan Keqian Biology
Segment by Type:
Live Vaccine
Inactivated Vaccine
Segment by Application
Calf
Adult Cow
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rinderpest Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Rinderpest Virus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Rinderpest Virus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Rinderpest Virus Vaccine Product Introduction
1.2 Global Rinderpest Virus Vaccine Market Size Forecast
1.2.1 Global Rinderpest Virus Vaccine Sales Value (2019-2030)
1.2.2 Global Rinderpest Virus Vaccine Sales Volume (2019-2030)
1.2.3 Global Rinderpest Virus Vaccine Sales Price (2019-2030)
1.3 Rinderpest Virus Vaccine Market Trends & Drivers
1.3.1 Rinderpest Virus Vaccine Industry Trends
1.3.2 Rinderpest Virus Vaccine Market Drivers & Opportunity
1.3.3 Rinderpest Virus Vaccine Market Challenges
1.3.4 Rinderpest Virus Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Rinderpest Virus Vaccine Players Revenue Ranking (2023)
2.2 Global Rinderpest Virus Vaccine Revenue by Company (2019-2024)
2.3 Global Rinderpest Virus Vaccine Players Sales Volume Ranking (2023)
2.4 Global Rinderpest Virus Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Rinderpest Virus Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Rinderpest Virus Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Rinderpest Virus Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Rinderpest Virus Vaccine
2.9 Rinderpest Virus Vaccine Market Competitive Analysis
2.9.1 Rinderpest Virus Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Rinderpest Virus Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rinderpest Virus Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Vaccine
3.1.2 Inactivated Vaccine
3.2 Global Rinderpest Virus Vaccine Sales Value by Type
3.2.1 Global Rinderpest Virus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Rinderpest Virus Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Rinderpest Virus Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Rinderpest Virus Vaccine Sales Volume by Type
3.3.1 Global Rinderpest Virus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Rinderpest Virus Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Rinderpest Virus Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Rinderpest Virus Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Calf
4.1.2 Adult Cow
4.2 Global Rinderpest Virus Vaccine Sales Value by Application
4.2.1 Global Rinderpest Virus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Rinderpest Virus Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Rinderpest Virus Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Rinderpest Virus Vaccine Sales Volume by Application
4.3.1 Global Rinderpest Virus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Rinderpest Virus Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Rinderpest Virus Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Rinderpest Virus Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Rinderpest Virus Vaccine Sales Value by Region
5.1.1 Global Rinderpest Virus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Rinderpest Virus Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Rinderpest Virus Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Rinderpest Virus Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Rinderpest Virus Vaccine Sales Volume by Region
5.2.1 Global Rinderpest Virus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Rinderpest Virus Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Rinderpest Virus Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Rinderpest Virus Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Rinderpest Virus Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Rinderpest Virus Vaccine Sales Value, 2019-2030
5.4.2 North America Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Rinderpest Virus Vaccine Sales Value, 2019-2030
5.5.2 Europe Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Rinderpest Virus Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Rinderpest Virus Vaccine Sales Value, 2019-2030
5.7.2 South America Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Rinderpest Virus Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Rinderpest Virus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Rinderpest Virus Vaccine Sales Value
6.2.1 Key Countries/Regions Rinderpest Virus Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Rinderpest Virus Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Rinderpest Virus Vaccine Sales Value, 2019-2030
6.3.2 United States Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Rinderpest Virus Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Rinderpest Virus Vaccine Sales Value, 2019-2030
6.4.2 Europe Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Rinderpest Virus Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Rinderpest Virus Vaccine Sales Value, 2019-2030
6.5.2 China Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Rinderpest Virus Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Rinderpest Virus Vaccine Sales Value, 2019-2030
6.6.2 Japan Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Rinderpest Virus Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Rinderpest Virus Vaccine Sales Value, 2019-2030
6.7.2 South Korea Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Rinderpest Virus Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Rinderpest Virus Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Rinderpest Virus Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Rinderpest Virus Vaccine Sales Value, 2019-2030
6.9.2 India Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Rinderpest Virus Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Company Information
7.1.2 Zoetis Introduction and Business Overview
7.1.3 Zoetis Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Rinderpest Virus Vaccine Product Offerings
7.1.5 Zoetis Recent Development
7.2 Merck Animal Health
7.2.1 Merck Animal Health Company Information
7.2.2 Merck Animal Health Introduction and Business Overview
7.2.3 Merck Animal Health Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Animal Health Rinderpest Virus Vaccine Product Offerings
7.2.5 Merck Animal Health Recent Development
7.3 Hipra
7.3.1 Hipra Company Information
7.3.2 Hipra Introduction and Business Overview
7.3.3 Hipra Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Hipra Rinderpest Virus Vaccine Product Offerings
7.3.5 Hipra Recent Development
7.4 Boehringer-Ingelheim
7.4.1 Boehringer-Ingelheim Company Information
7.4.2 Boehringer-Ingelheim Introduction and Business Overview
7.4.3 Boehringer-Ingelheim Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boehringer-Ingelheim Rinderpest Virus Vaccine Product Offerings
7.4.5 Boehringer-Ingelheim Recent Development
7.5 Ceva
7.5.1 Ceva Company Information
7.5.2 Ceva Introduction and Business Overview
7.5.3 Ceva Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ceva Rinderpest Virus Vaccine Product Offerings
7.5.5 Ceva Recent Development
7.6 Creative Biolabs
7.6.1 Creative Biolabs Company Information
7.6.2 Creative Biolabs Introduction and Business Overview
7.6.3 Creative Biolabs Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Creative Biolabs Rinderpest Virus Vaccine Product Offerings
7.6.5 Creative Biolabs Recent Development
7.7 China Animal Husbandry Industry
7.7.1 China Animal Husbandry Industry Company Information
7.7.2 China Animal Husbandry Industry Introduction and Business Overview
7.7.3 China Animal Husbandry Industry Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 China Animal Husbandry Industry Rinderpest Virus Vaccine Product Offerings
7.7.5 China Animal Husbandry Industry Recent Development
7.8 Jinyu Bio-technology
7.8.1 Jinyu Bio-technology Company Information
7.8.2 Jinyu Bio-technology Introduction and Business Overview
7.8.3 Jinyu Bio-technology Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jinyu Bio-technology Rinderpest Virus Vaccine Product Offerings
7.8.5 Jinyu Bio-technology Recent Development
7.9 TECON
7.9.1 TECON Company Information
7.9.2 TECON Introduction and Business Overview
7.9.3 TECON Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 TECON Rinderpest Virus Vaccine Product Offerings
7.9.5 TECON Recent Development
7.10 Shenzhen Huaweite Biotechnology
7.10.1 Shenzhen Huaweite Biotechnology Company Information
7.10.2 Shenzhen Huaweite Biotechnology Introduction and Business Overview
7.10.3 Shenzhen Huaweite Biotechnology Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Shenzhen Huaweite Biotechnology Rinderpest Virus Vaccine Product Offerings
7.10.5 Shenzhen Huaweite Biotechnology Recent Development
7.11 Beijing Centrebio Biology
7.11.1 Beijing Centrebio Biology Company Information
7.11.2 Beijing Centrebio Biology Introduction and Business Overview
7.11.3 Beijing Centrebio Biology Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Beijing Centrebio Biology Rinderpest Virus Vaccine Product Offerings
7.11.5 Beijing Centrebio Biology Recent Development
7.12 Guangdong Winsun Bio Pharmaceutical
7.12.1 Guangdong Winsun Bio Pharmaceutical Company Information
7.12.2 Guangdong Winsun Bio Pharmaceutical Introduction and Business Overview
7.12.3 Guangdong Winsun Bio Pharmaceutical Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Guangdong Winsun Bio Pharmaceutical Rinderpest Virus Vaccine Product Offerings
7.12.5 Guangdong Winsun Bio Pharmaceutical Recent Development
7.13 SPAH
7.13.1 SPAH Company Information
7.13.2 SPAH Introduction and Business Overview
7.13.3 SPAH Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 SPAH Rinderpest Virus Vaccine Product Offerings
7.13.5 SPAH Recent Development
7.14 Wuhan Keqian Biology
7.14.1 Wuhan Keqian Biology Company Information
7.14.2 Wuhan Keqian Biology Introduction and Business Overview
7.14.3 Wuhan Keqian Biology Rinderpest Virus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Wuhan Keqian Biology Rinderpest Virus Vaccine Product Offerings
7.14.5 Wuhan Keqian Biology Recent Development
8 Industry Chain Analysis
8.1 Rinderpest Virus Vaccine Industrial Chain
8.2 Rinderpest Virus Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Rinderpest Virus Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Rinderpest Virus Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Rinderpest Virus Vaccine Market Trends
Table 2. Rinderpest Virus Vaccine Market Drivers & Opportunity
Table 3. Rinderpest Virus Vaccine Market Challenges
Table 4. Rinderpest Virus Vaccine Market Restraints
Table 5. Global Rinderpest Virus Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Rinderpest Virus Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Rinderpest Virus Vaccine Sales Volume by Company (2019-2024) & (K Doses)
Table 8. Global Rinderpest Virus Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Rinderpest Virus Vaccine Price by Company (2019-2024) & (US$/Dose)
Table 10. Key Manufacturers Rinderpest Virus Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Rinderpest Virus Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Rinderpest Virus Vaccine
Table 13. Global Rinderpest Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rinderpest Virus Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Rinderpest Virus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Rinderpest Virus Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Rinderpest Virus Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Rinderpest Virus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Rinderpest Virus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Rinderpest Virus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Doses)
Table 22. Global Rinderpest Virus Vaccine Sales Volume by Type (2019-2024) & (K Doses)
Table 23. Global Rinderpest Virus Vaccine Sales Volume by Type (2025-2030) & (K Doses)
Table 24. Global Rinderpest Virus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Rinderpest Virus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Rinderpest Virus Vaccine Price by Type (2019-2024) & (US$/Dose)
Table 27. Global Rinderpest Virus Vaccine Price by Type (2025-2030) & (US$/Dose)
Table 28. Global Rinderpest Virus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Rinderpest Virus Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Rinderpest Virus Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Rinderpest Virus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Rinderpest Virus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Rinderpest Virus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Doses)
Table 34. Global Rinderpest Virus Vaccine Sales Volume by Application (2019-2024) & (K Doses)
Table 35. Global Rinderpest Virus Vaccine Sales Volume by Application (2025-2030) & (K Doses)
Table 36. Global Rinderpest Virus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Rinderpest Virus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Rinderpest Virus Vaccine Price by Application (2019-2024) & (US$/Dose)
Table 39. Global Rinderpest Virus Vaccine Price by Application (2025-2030) & (US$/Dose)
Table 40. Global Rinderpest Virus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Rinderpest Virus Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Rinderpest Virus Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Rinderpest Virus Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Rinderpest Virus Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Rinderpest Virus Vaccine Sales Volume by Region (K Doses): 2019 VS 2023 VS 2030
Table 46. Global Rinderpest Virus Vaccine Sales Volume by Region (2019-2024) & (K Doses)
Table 47. Global Rinderpest Virus Vaccine Sales Volume by Region (2025-2030) & (K Doses)
Table 48. Global Rinderpest Virus Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Rinderpest Virus Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Rinderpest Virus Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 51. Global Rinderpest Virus Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 52. Key Countries/Regions Rinderpest Virus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Rinderpest Virus Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Rinderpest Virus Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Rinderpest Virus Vaccine Sales Volume, (2019-2024) & (K Doses)
Table 56. Key Countries/Regions Rinderpest Virus Vaccine Sales Volume, (2025-2030) & (K Doses)
Table 57. Zoetis Company Information
Table 58. Zoetis Introduction and Business Overview
Table 59. Zoetis Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. Zoetis Rinderpest Virus Vaccine Product Offerings
Table 61. Zoetis Recent Development
Table 62. Merck Animal Health Company Information
Table 63. Merck Animal Health Introduction and Business Overview
Table 64. Merck Animal Health Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. Merck Animal Health Rinderpest Virus Vaccine Product Offerings
Table 66. Merck Animal Health Recent Development
Table 67. Hipra Company Information
Table 68. Hipra Introduction and Business Overview
Table 69. Hipra Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. Hipra Rinderpest Virus Vaccine Product Offerings
Table 71. Hipra Recent Development
Table 72. Boehringer-Ingelheim Company Information
Table 73. Boehringer-Ingelheim Introduction and Business Overview
Table 74. Boehringer-Ingelheim Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Boehringer-Ingelheim Rinderpest Virus Vaccine Product Offerings
Table 76. Boehringer-Ingelheim Recent Development
Table 77. Ceva Company Information
Table 78. Ceva Introduction and Business Overview
Table 79. Ceva Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Ceva Rinderpest Virus Vaccine Product Offerings
Table 81. Ceva Recent Development
Table 82. Creative Biolabs Company Information
Table 83. Creative Biolabs Introduction and Business Overview
Table 84. Creative Biolabs Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Creative Biolabs Rinderpest Virus Vaccine Product Offerings
Table 86. Creative Biolabs Recent Development
Table 87. China Animal Husbandry Industry Company Information
Table 88. China Animal Husbandry Industry Introduction and Business Overview
Table 89. China Animal Husbandry Industry Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. China Animal Husbandry Industry Rinderpest Virus Vaccine Product Offerings
Table 91. China Animal Husbandry Industry Recent Development
Table 92. Jinyu Bio-technology Company Information
Table 93. Jinyu Bio-technology Introduction and Business Overview
Table 94. Jinyu Bio-technology Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Jinyu Bio-technology Rinderpest Virus Vaccine Product Offerings
Table 96. Jinyu Bio-technology Recent Development
Table 97. TECON Company Information
Table 98. TECON Introduction and Business Overview
Table 99. TECON Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. TECON Rinderpest Virus Vaccine Product Offerings
Table 101. TECON Recent Development
Table 102. Shenzhen Huaweite Biotechnology Company Information
Table 103. Shenzhen Huaweite Biotechnology Introduction and Business Overview
Table 104. Shenzhen Huaweite Biotechnology Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Shenzhen Huaweite Biotechnology Rinderpest Virus Vaccine Product Offerings
Table 106. Shenzhen Huaweite Biotechnology Recent Development
Table 107. Beijing Centrebio Biology Company Information
Table 108. Beijing Centrebio Biology Introduction and Business Overview
Table 109. Beijing Centrebio Biology Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Beijing Centrebio Biology Rinderpest Virus Vaccine Product Offerings
Table 111. Beijing Centrebio Biology Recent Development
Table 112. Guangdong Winsun Bio Pharmaceutical Company Information
Table 113. Guangdong Winsun Bio Pharmaceutical Introduction and Business Overview
Table 114. Guangdong Winsun Bio Pharmaceutical Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 115. Guangdong Winsun Bio Pharmaceutical Rinderpest Virus Vaccine Product Offerings
Table 116. Guangdong Winsun Bio Pharmaceutical Recent Development
Table 117. SPAH Company Information
Table 118. SPAH Introduction and Business Overview
Table 119. SPAH Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 120. SPAH Rinderpest Virus Vaccine Product Offerings
Table 121. SPAH Recent Development
Table 122. Wuhan Keqian Biology Company Information
Table 123. Wuhan Keqian Biology Introduction and Business Overview
Table 124. Wuhan Keqian Biology Rinderpest Virus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 125. Wuhan Keqian Biology Rinderpest Virus Vaccine Product Offerings
Table 126. Wuhan Keqian Biology Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Rinderpest Virus Vaccine Downstream Customers
Table 130. Rinderpest Virus Vaccine Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Rinderpest Virus Vaccine Product Picture
Figure 2. Global Rinderpest Virus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Rinderpest Virus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Rinderpest Virus Vaccine Sales Volume (2019-2030) & (K Doses)
Figure 5. Global Rinderpest Virus Vaccine Sales Price (2019-2030) & (US$/Dose)
Figure 6. Rinderpest Virus Vaccine Report Years Considered
Figure 7. Global Rinderpest Virus Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Rinderpest Virus Vaccine Players Sales Volume Ranking (2023) & (K Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Rinderpest Virus Vaccine Revenue in 2023
Figure 10. Rinderpest Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Live Vaccine Picture
Figure 12. Inactivated Vaccine Picture
Figure 13. Global Rinderpest Virus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Rinderpest Virus Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Rinderpest Virus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 16. Global Rinderpest Virus Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Rinderpest Virus Vaccine Price by Type (2019-2030) & (US$/Dose)
Figure 18. Product Picture of Calf
Figure 19. Product Picture of Adult Cow
Figure 20. Global Rinderpest Virus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Rinderpest Virus Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Rinderpest Virus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 23. Global Rinderpest Virus Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Rinderpest Virus Vaccine Price by Application (2019-2030) & (US$/Dose)
Figure 25. North America Rinderpest Virus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Rinderpest Virus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Rinderpest Virus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Rinderpest Virus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Rinderpest Virus Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Rinderpest Virus Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Rinderpest Virus Vaccine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Rinderpest Virus Vaccine Sales Volume (%), (2019-2030)
Figure 37. United States Rinderpest Virus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Rinderpest Virus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Rinderpest Virus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Rinderpest Virus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Rinderpest Virus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Rinderpest Virus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Rinderpest Virus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Rinderpest Virus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Rinderpest Virus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Rinderpest Virus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Rinderpest Virus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Rinderpest Virus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Rinderpest Virus Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Rinderpest Virus Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Rinderpest Virus Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 58. Rinderpest Virus Vaccine Industrial Chain
Figure 59. Rinderpest Virus Vaccine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
